Cudarolimab (Anti-TNFRSF4 / OX40 / CD134)

Cudarolimab (Anti-TNFRSF4 / OX40 / CD134) is an agonistic fully human anti-OX40 (tumor necrosis factor receptor superfamily member 4, TNFRSF4, CD134, OX40L receptor) with potential immune checkpoint inhibitory and antineoplastic activities. MW : 145.94 KD.
Supplier Selleck Chemicals
Product # A2814
Sku # A2814-1mg*5
Pricing 1mg*5, $970.00
Feedback